Zhejiang AngLiKang Pharmaceutical CO.,LTD.
SZSE:002940.SZ
17.9 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| 183.065 | 131.987 | 141.322 | 181.301 | 126.458 | 121.669 | 105.433 | 80.932 | 58.098 | 41.506 |
| Depreciation & Amortization
| 78.777 | 61.104 | 46.357 | 41.694 | 38.15 | 39.236 | 33.215 | 33.734 | 36.28 | 34.067 |
| Deferred Income Tax
| -0.53 | -0.243 | 2.159 | -5.617 | 2.991 | -18.037 | -0.981 | 0.336 | 0.873 | 0 |
| Stock Based Compensation
| 0 | 1.874 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -21.846 | -24.042 | -5.42 | -35.704 | 31.643 | -19.216 | 44.797 | 7.838 | 21.696 | -46.64 |
| Accounts Receivables
| 86.634 | -47.823 | -39.994 | -51.434 | 109.618 | -39.988 | -94.668 | 40.292 | -31.635 | -73.74 |
| Inventory
| -23.819 | 2.06 | -25.152 | -152.207 | 30.104 | -21.161 | -15.28 | 6.643 | -0.649 | -46.507 |
| Accounts Payables
| -84.13 | 21.964 | 57.566 | 173.553 | -111.071 | 59.969 | 155.727 | -39.433 | 53.106 | 0 |
| Other Working Capital
| 1.974 | -0.243 | 2.159 | -5.617 | 2.991 | 1.945 | 60.077 | 1.195 | 22.344 | -0.133 |
| Other Non Cash Items
| 36.912 | 14.065 | 15.394 | 11.321 | 17.242 | -8.077 | 10.328 | 19.24 | 22.515 | 21.526 |
| Operating Cash Flow
| 276.909 | 184.747 | 197.652 | 198.613 | 213.493 | 133.612 | 193.773 | 141.745 | 138.588 | 50.458 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -124.946 | -68.823 | -87.318 | -90.964 | -75.584 | -68.172 | -54.787 | -25.813 | -35.103 | -48.476 |
| Acquisitions Net
| -117.484 | 17.561 | 0.376 | 0.202 | 0.197 | 68.219 | 3.606 | 0.596 | 0.01 | 1.862 |
| Purchases Of Investments
| -1.5 | -487.86 | -95 | -42.262 | -6.615 | -2.45 | -5.24 | 0 | -15.07 | -18.4 |
| Sales Maturities Of Investments
| 45.428 | 3.351 | 3.76 | 3.687 | 3.158 | 1.48 | 0.547 | 7.06 | 4.43 | 5.992 |
| Other Investing Activites
| 28.497 | 14.452 | -54.623 | 150 | -149.95 | -68.172 | 11.796 | 31.082 | -34.086 | 8.692 |
| Investing Cash Flow
| -170.006 | -521.32 | -232.805 | 20.663 | -228.794 | -69.095 | -44.077 | 12.329 | -79.819 | -50.329 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -163.14 | -27.986 | -12 | -10 | -15 | -80 | -127 | -202.8 | -357.754 | -244.63 |
| Common Stock Issued
| 0 | 63.324 | 63.339 | 0 | 0 | 464.633 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| -20.12 | -63.324 | -63.339 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -41.737 | -28.166 | -46.943 | -90 | -67.5 | -1.926 | -45.203 | -29.069 | -21.594 | -75.067 |
| Other Financing Activities
| -56.473 | 438.76 | -64.539 | 277.47 | -14.8 | 479.633 | 91.954 | 98.303 | 319.206 | 309.78 |
| Financing Cash Flow
| 15.651 | 376.616 | -123.598 | 177.405 | -97.339 | 397.707 | -80.248 | -133.566 | -60.142 | -9.917 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 1.162 | 1.275 | -0.578 | -0.334 | 0.059 | 0.461 | -0.797 | 1.111 | 0.923 | -0.007 |
| Net Change In Cash
| 123.717 | 41.318 | -159.329 | 396.347 | -112.58 | 462.686 | 68.65 | 21.618 | -0.45 | -9.795 |
| Cash At End Of Period
| 852.614 | 728.898 | 687.58 | 846.908 | 450.561 | 563.142 | 100.456 | 31.806 | 10.188 | 10.637 |